Claudia Schoch

Claudia Schoch publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Claudia Schoch sits on this spectrum.

Claudia Schoch D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Claudia Schoch sits on this spectrum.

Overview

Best Publications

• Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.

  Susanne Schnittger;Claudia Schoch;Martin Dugas;Wolfgang Kern

  1438
  Citations

• Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy.

  A. Hochhaus;S. Kreil;A. S. Corbin;P. La Rosée;P. La Rosée

  1210
  Citations

• Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

  Susanne Schnittger;Claudia Schoch;Wolfgang Kern;Cristina Mecucci

  908
  Citations

• AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.

  Thomas Pabst;Beatrice U. Mueller;Nari Harakawa;Claudia Schoch

  596
  Citations

• KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

  Susanne Schnittger;Tobias M. Kohl;Torsten Haferlach;Wolfgang Kern

  512
  Citations

• Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group.

  Thomas Büchner;Wolfgang Hiddemann;Bernhard Wörmann;Helmut Löffler

  495
  Citations

• AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases

  Claudia Schoch;Susanne Schnittger;Mirjam Klaus;Wolfgang Kern

  443
  Citations

• Diversity and Functional Consequences of Germline and Somatic PTPN11 Mutations in Human Disease

  Marco Tartaglia;Simone Martinelli;Lorenzo Stella;Gianfranco Bocchinfuso

  435
  Citations

• Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases

  C Schoch;S Schnittger;S Bursch;D Gerstner

  419
  Citations

• Implications of NRAS mutations in AML: a study of 2502 patients.

  Ulrike Bacher;Torsten Haferlach;Claudia Schoch;Wolfgang Kern

  408
  Citations

• Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML

  S Schnittger;U Kinkelin;C Schoch;A Heinecke

  406
  Citations

• Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

  Wolfgang Kern;Torsten Haferlach;Claudia Schoch;Helmut Löffler

  398
  Citations

• Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML.

  C Schoch;W Kern;S Schnittger;W Hiddemann

  392
  Citations

• The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2

  Andreas Reiter;Christoph Walz;Ann Watmore;Claudia Schoch

  347
  Citations

• Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia.

  Wolfgang Kern;Daniela Voskova;Claudia Schoch;Wolfgang Hiddemann

  346
  Citations

• Management of Acute Myeloid Leukemia in Elderly Patients

  Wolfgang Hiddemann;Wolfgang Kern;Claudia Schoch;Christa Fonatsch

  335
  Citations

• Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles.

  Claudia Schoch;Alexander Kohlmann;Alexander Kohlmann;Susanne Schnittger;Susanne Schnittger;Benedikt Brors;Benedikt Brors

  329
  Citations

• The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.

  Rajani K. Vangala;Marion S. Heiss-Neumann;Marion S. Heiss-Neumann;Janki S. Rangatia;Janki S. Rangatia;Sheo M. Singh;Sheo M. Singh

  312
  Citations

• Global approach to the diagnosis of leukemia using gene expression profiling.

  Torsten Haferlach;Alexander Kohlmann;Susanne Schnittger;Martin Dugas

  298
  Citations

• The MLL recombinome of acute leukemias.

  C. Meyer;B. Schneider;S. Jakob;S. Strehl

  280
  Citations